Dr.
Wellcome Sanger Institute, United Kingdom
Matt is a postdoctoral researcher in Dr. Mathew Garnett's laboratory, Wellcome Sanger Institute, focussing on functional genomics strategies to understand molecular pathways involved in sensitivity to cancer immunotherapies. Matt has gained prior expertise in cancer immunotherapy in the laboratory of Prof. Julian Downward at the Francis Crick Institute, and CRISPR and base editing technologies at AstraZeneca.
High-throughput functional genomics using CRISPR base editing in cancer cells
Wednesday, May 24, 2023
15:00 – 15:30 CET